Changes in the legal framework, successful market entry and IP protection for pharma and biotech products in China
Thursday, 26. February 2019 | 10:00 – 11:00 EST / 16:00 – 17:00 CET
China is the world's second largest market for pharmaceuticals and medical devices. Many Western manufacturers are still reluctant in entering the Chinese market. So far, their reasoning often included non-transparent regulations and unfavorable procedures for foreign companies.
CHINABRAND CONSULTING will show in this free-of-charge one-hour webinar how the legal framework has changed and what pharmaceutical and biotech companies need to consider when entering and developing the Chinese market. The contents include:
To register, find the link on our website or send us an e-mail.